Wearable medical sensors have opened doors for remote health monitoring and treatment evaluation. But making diagnoses and treatment plans based on many datapoints—such as muscle movements, heart rate, breathing or speaking ...
Dec 19, 2023
0
33
Researchers now understand the functional impact of thousands of genetic changes within the DDX3X gene. This could lead to enhanced diagnosis and treatment of various neurodevelopmental disorders and cancers.
Dec 6, 2023
0
16
A group of international scientists say they have encountered many hurdles in accessing information for a study to examine clinical trial data used to support FDA-approved anticancer medicines even when the data was classified ...
Nov 15, 2023
0
22
A model based on artificial intelligence is able to predict the therapy outcome (measured by volumetric reduction of tumor lesions) in 80% of ovarian cancer patients. The AI-based model has an accuracy of 80%, significantly ...
Nov 13, 2023
0
17
A new study has shed light on why immunotherapy does not always work in certain types of cancer. Led by researchers at EMBL's European Bioinformatics Institute (EMBL-EBI), Cold Spring Harbor Laboratory (CSHL), and the Massachusetts ...
Sep 14, 2023
0
25
Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive ...
Sep 4, 2023
0
44
A study led by Johns Hopkins University researchers suggests that the use of pulse oximeters in hospitalized COVID-19 patients often overestimated true arterial oxygen saturation (SaO2), especially in those of minority race, ...
Aug 25, 2023
2
94
Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models.
Aug 21, 2023
0
49
The Medicaid expansion under the Patient Protection and Affordable Care Act resulted in a 19% annual increase in Medicaid-insured cancer patients participating in publicly funded clinical trials, according to researchers ...
Aug 17, 2023
0
70
For a small percentage of cancer patients, doctors are unable to determine where their cancer originated. This makes it much more difficult to choose a treatment for those patients, because many cancer drugs are typically ...
Aug 7, 2023
0
34
